| Home | E-Submission | Sitemap | Editorial Office
top_img
    
REVIEW
Current status and strategies for viral hepatitis control in Korea
Viral hepatitis is one of major global health challenges with increasing disease burden worldwide. Hepatitis B virus and hepatitis C virus infections are major causes of chronic liver diseases. They can lead to cirrhosis, hepatocellular carcinoma, and death in significant portio...
REVIEW
Current status and strategies for the control of viral hepatitis A in Korea
Hepatitis A virus is one of the most frequent causes of foodborne infection, which is closely associated with sanitary conditions and hygienic practices. The clinical spectrum of acute hepatitis A is wide, ranging from mild case without any noticeable symptoms to severe case wit...
REVIEW
Current status and strategies for hepatitis B control in Korea
Hepatitis B virus (HBV) infection is the most common cause of chronic liver diseases in Korea. After the introduction of the universal HBV vaccination program, the prevalence of hepatitis B surface antigen was markedly reduced, and Korea is now classified as an area of intermedi...
ORIGINAL ARTICLE
Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?
Background/Aims: Surveillance for hepatocellular carcinoma (HCC) with ultrasound in high-risk populations is generally believed to improve opportunities for treatment. However, tumors are still missed due to various factors. This study explores success versus failure of HCC surv...
Current Issue
Volume 23(3); Sep 2017
Volume 23(2); June 2017
Volume 23(1); March 2017
Volume 22(4); December 2016
Volume 22(3); September 2016
RSS feed
  • Most-cited are based on citations from 2015 ~ 2017.

    A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016
    Su Jong Yu
    Clin Mol Hepatol.2016;22(1):7-17.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.7
                                     Cited By 33
    KASL clinical practice guidelines: management of chronic hepatitis B
    Clin Mol Hepatol.2016;22(1):18-75.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.18
                                     Cited By 31
    Hepatitis C virus-induced hepatocellular carcinoma
    Nicolas Goossens, Yujin Hoshida
    Clin Mol Hepatol.2015;21(2):105-114.   Published online June 26, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.2.105
                                     Cited By 26
    The mutational landscape of hepatocellular carcinoma
    Ju-Seog Lee
    Clin Mol Hepatol.2015;21(3):220-229.   Published online September 30, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.3.220
                                     Cited By 16
    Clinical implications of advances in liver regeneration
    Yong Jin Kwon, Kyeong Geun Lee, Dongho Choi
    Clin Mol Hepatol.2015;21(1):7-13.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.7
                                     Cited By 15
    Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis
    Yoon Ok Jang, Baek Gyu Jun, Soon Koo Baik, Moon Young Kim, Sang Ok Kwon
    Clin Mol Hepatol.2015;21(2):141-149.   Published online June 26, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.2.141
                                     Cited By 14
    Personalized management of cirrhosis by non-invasive tests of liver fibrosis
    Grace Lai-Hung Wong, Wendell Zaragoza Espinosa, Vicnent Wai-Sun Wong
    Clin Mol Hepatol.2015;21(3):200-211.   Published online September 30, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.3.200
                                     Cited By 13
    KASL clinical practice guidelines: management of hepatitis C
    The Korean Association for the Study of the Liver (KASL)
    Clin Mol Hepatol.2016;22(1):76-139.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.76
                                     Cited By 12
    The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease
    Goh Eun Chung, Donghee Kim, Min-Sun Kwak, Jong In Yang, Jeong Yoon Yim, Seon Hee Lim, Mustafa Itani
    Clin Mol Hepatol.2016;22(1):146-151.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.146
                                     Cited By 12
    New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis
    Hyun Young Woo, Jeong Heo
    Clin Mol Hepatol.2015;21(2):115-121.   Published online June 26, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.2.115
                                     Cited By 11
    Personalized treatment of hepatitis B
    Anna S. Lok
    Clin Mol Hepatol.2015;21(1):1-6.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.1
                                     Cited By 10
    The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B
    In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
    Clin Mol Hepatol.2015;21(1):32-40.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.32
                                     Cited By 9
    Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase
    Yasuko Iwakiri
    Clin Mol Hepatol.2015;21(4):319-325.   Published online December 24, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.4.319
                                     Cited By 9
    Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease
    Chansik An, Youn Ah Choi, Dongil Choi, Yong Han Paik, Sang Hoon Ahn, Myeong-Jin Kim, Seung Woon Paik, Kwang-Hyub Han, Mi-Suk Park
    Clin Mol Hepatol.2015;21(3):279-286.   Published online September 30, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.3.279
                                     Cited By 8
    Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients
    Sang Kyung Jung, Kyung-Ah Kim, So Young Ha, Hyun Kyo Lee, Young Doo Kim, Bu Hyun Lee, Woo Hyun Paik, Jong Wook Kim, Won Ki Bae, Nam-Hoon Kim, June Sung Lee, Yoon Jung Jwa
    Clin Mol Hepatol.2015;21(1):41-48.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.41
                                     Cited By 7
    Acute-on-chronic liver failure: a new syndrome in cirrhosis
    Richard Moreau
    Clin Mol Hepatol.2016;22(1):1-6.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.1
                                     Cited By 7
    Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis
    Jung Min Lee, Byoung Kuk Jang, Yoo Jin Lee, Wang Yong Choi, Sei Myong Choi, Woo Jin Chung, Jae Seok Hwang, Koo Jeong Kang, Young Hwan Kim, Anil Kumar Chauhan, Soo Young Park, Won Young Tak, Young Oh Kweon, Byung Seok Kim, Chang Hyeong Lee
    Clin Mol Hepatol.2016;22(1):160-167.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.160
                                     Cited By 7
    Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment
    Hyunwoo Oh, Dae Won Jun, Waqar K Saeed, Mindie H Nguyen
    Clin Mol Hepatol.2016;22(3):327-335.   Published online September 25, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.0049
                                     Cited By 7
    Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir
    Han Na Choi, Jeong Eun Song, Hyeon Chul Lee, Hyeong Ho Jo, Chang Hyeong Lee, Byung Seok Kim
    Clin Mol Hepatol.2015;21(1):24-31.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.24
                                     Cited By 6
    Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy
    Jung Gil Park
    Clin Mol Hepatol.2015;21(3):287-294.   Published online September 30, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.3.287
                                     Cited By 6
  • Editorial Office
    The Korean Association for the Study of the Liver
    Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
    TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
    About |  Browse Articles |  Current Issue |  For Authors and Reviewers
    Copyright © The Korean Association for the Study of the Liver. All rights reserved.